Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 3, 2008

View Archived Issues

Targeting galectin-1 may be useful to prevent pregnancy loss

Studies support serotonin inverse agonist combination therapy for schizophrenia

New site-directed nanoparticle delivery system useful to treat ocular inflammation in vivo

Cognition-enhancing activity of novel inverse agonist of GABA-A alpha 5 subunit receptors

Modulation of LR11 protein levels by dietary DHA may be beneficial for AD prevention

AstraZeneca submits sNDAs for Seroquel XR tablets

Can-Fite collaborates with academic institutes to develop CF-102

Efexor XL indication in U.K. now includes moderate-severe generalized SAD/social phobia

Innocoll doses first patient in phase III gentamicin surgical implant trial

NeoPharm files IND for novel docetaxel liposomal delivery system

Pfizer completes tender offer relating to outstanding shares of Coley Pharmaceutical

Recent Jerini patent discloses novel agents for ocular disorders

Pfizer launches Ecalta for invasive candidiasis in non-neutropenic patients

Positive results reported for Zybrestat in platinum-resistant ovarian cancer

Prana Biotechnology completes phase IIa trial of PBT-2 in Alzheimer's disease

Recent patents impart novel analgesic agents

FDA approves Sciele Pharma's new Sular formulation

FDA assigns priority review status to Schering-Plough's NDA for sugammadex

New HIV aspartyl protease inhibitors disclosed in recent Tibotec patent

Recent patents describe new antidiabetic agents

Sepracor and Bial collaborate on antiepileptic compound in U.S. and Canada

Positive preclinical ocular penetration data reported for topical Zybrestat in ophthalmology

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...